These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 822138)

  • 1. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ; Francis MD
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentisic acid: a new stabilizer for low tin skeletal imaging agents: concise communication.
    Tofe AJ; Bevan JA; Fawzi MB; Francis MD; Silberstein EB; Alexander GA; Gunderson DE; Blair K
    J Nucl Med; 1980 Apr; 21(4):366-70. PubMed ID: 7381564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two different HEDP content kits: stability study against dilution both in vivo and in vitro.
    Inoue O; Ikeda I; Kurata K
    Nuklearmedizin; 1982 Jun; 21(3):121-5. PubMed ID: 6813826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
    Vucina J
    Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo behaviour of four different 99(m)Tc-HEDP complexes.
    Inoue O; Yamaguchi T; Ikeda I
    Nuklearmedizin; 1982 Dec; 21(6):227-31. PubMed ID: 6820139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.
    Khentigan A; Garrett M; Lum D; Winchell HS
    J Nucl Med; 1976 May; 17(5):380-4. PubMed ID: 1262943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complexes 99mTc-Sn-DTPA, 99mTc-Fe-ascorbic acid, and 99mTc-Sn-calcium-gluconogalactogluconate in the diagnosis of renal function and morphology (author's transl)].
    Licińska I; Graban W; Jakubowski W; Krasucki T; Lachnik E; Wiza J; Zulczyk W; Smoliński S; Zielińska B
    Pol Przegl Radiol Med Nukl; 1977; 41(1):57-61. PubMed ID: 859758
    [No Abstract]   [Full Text] [Related]  

  • 10. New preparation method for 99mTc-phytate.
    Ikeda I; Inoue O; Kurata K
    J Nucl Med; 1976 May; 17(5):389-93. PubMed ID: 1262944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the in vivo properties of 99mTc-HEDP.
    Citrin DL
    Radiology; 1977 Jan; 122(1):255-8. PubMed ID: 401461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
    Haynie TP; Konikowski T; Glenn HJ
    J Nucl Med; 1977 Sep; 18(9):915-8. PubMed ID: 893790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues.
    Silberstein EB; Francis MD; Tofe AJ; Slough CL
    J Nucl Med; 1975 Jan; 16(1):58-61. PubMed ID: 162948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
    Schümichen C; Mackenbrock B; Hoffmann G
    Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
    [No Abstract]   [Full Text] [Related]  

  • 18. 99mTc-thiomalic acid complex: a nonstannous chelate for renal scanning.
    Hagan PL; Chauncey DM; Halpern SE; Ayres PR
    J Nucl Med; 1977 Apr; 18(4):353-9. PubMed ID: 845664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
    Citrin DL; Bessent RG; McGinley E; Gordon D
    J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
    Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
    Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.